Seladelpar lysine dihydrate  MBX-8052

一、产品概述

Seladelpar lysine dihydrate是由Cymabay Therapeutics Inc研发的一种小分子药物，是一种PPARδ激动剂。该药物于2024年08月14日获FDA批准，用于治疗硬化性胆管炎。

二、主要产品

Description	Structural Formula	CAS No.	Category
Seladelpar lysine dihydrate		928821-40-3	API
ethyl   2-(4-mercapto-2-methylphenoxy)acetate		343322-82-7	intermediates
(R)-2-((4-(trifluoromethyl)phenoxy)methyl)oxirane		256372-58-4	intermediates

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.